125 related articles for article (PubMed ID: 7127336)
1. Etoposide in the treatment of refractory breast cancer.
Höffken K
Cancer Treat Rev; 1982 Jun; 9 Suppl():63-6. PubMed ID: 7127336
[No Abstract] [Full Text] [Related]
2. Etoposide salvage therapy for refractory germ cell tumors: an update.
Williams SD; Einhorn LH
Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer.
Ahmann DL; Bisel HF; Eagan RT; Edmonson JH; Hahn RG; O'Connell MJ; Frytak S
Cancer Treat Rep; 1976 May; 60(5):633-5. PubMed ID: 1036468
[No Abstract] [Full Text] [Related]
4. Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
Perez Manga G; Madrigal Alonso P; Alburquerque Carbuccia H
Cancer Chemother Pharmacol; 1982; 7(2-3):231-3. PubMed ID: 6896298
[No Abstract] [Full Text] [Related]
5. Mitomycin-C, VP16-213 combination as third line chemotherapy in advanced breast cancer.
Perez Manga G; Madrigal Alonso PL; Alburquerque Carbuccia H
Cancer Chemother Pharmacol; 1982; 7(2-3):227-9. PubMed ID: 6805972
[No Abstract] [Full Text] [Related]
6. Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.
Schell FC; Yap HY; Hortobagyi GN; Issell B; Esparza L
Cancer Chemother Pharmacol; 1982; 7(2-3):223-5. PubMed ID: 7083463
[No Abstract] [Full Text] [Related]
7. Etoposide for therapy-resistant testicular tumors.
Varini M; Cavalli F
Cancer Treat Rev; 1982 Jun; 9 Suppl():73-8. PubMed ID: 7127337
[No Abstract] [Full Text] [Related]
8. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
Eagan RT
Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
[No Abstract] [Full Text] [Related]
9. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
Goldhirsch A; Joss R; Cavalli F; Brunner KW
Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
[No Abstract] [Full Text] [Related]
10. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
[No Abstract] [Full Text] [Related]
11. Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
Eagan RT; Ahmann DL; Bisel HF
Oncology; 1976; 33(3):146-8. PubMed ID: 1012648
[TBL] [Abstract][Full Text] [Related]
12. [Prospects of new chemotherapies].
Sculier JP; Klastersky J
Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
[No Abstract] [Full Text] [Related]
13. [Randomized phase II study with VP-16-213 (etoposide) in the treatment of advanced breast cancer].
Cavalli F; Jungi WF; Brunner KW
Onkologie; 1981 Apr; 4(2):80-3. PubMed ID: 7022286
[TBL] [Abstract][Full Text] [Related]
14. A review of etoposide in patients with non-small-cell lung cancer (NSCLC).
Itri LM; Gralla RJ
Cancer Treat Rev; 1982 Jun; 9 Suppl():115-8. PubMed ID: 6889916
[No Abstract] [Full Text] [Related]
15. Etoposide--chemistry, preclinical and clinical pharmacology.
Achterrath W; Niederle N; Raettig R; Hilgard P
Cancer Treat Rev; 1982 Jun; 9 Suppl():3-13. PubMed ID: 7127334
[No Abstract] [Full Text] [Related]
16. Etoposide--an effective single drug for treating bronchogenic carcinoma.
Anderson G; Peel ET; Cheong CM; Broderick NJ
Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
[No Abstract] [Full Text] [Related]
17. Etoposide in the treatment of acute leukemia in adults.
Varini M; Cavalli F; Sauter C
Cancer Treat Rev; 1982 Jun; 9 Suppl():59-62. PubMed ID: 7127335
[No Abstract] [Full Text] [Related]
18. Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
Konits PH; Van Echo DA; Aisner J; Morris D; Wiernik PH
Am J Clin Oncol; 1982 Oct; 5(5):515-9. PubMed ID: 6758569
[TBL] [Abstract][Full Text] [Related]
19. VP-16-213 (etoposide): the mandrake root from Issyk-Kul.
Vogelzang NJ; Raghavan D; Kennedy BJ
Am J Med; 1982 Jan; 72(1):136-44. PubMed ID: 6277188
[TBL] [Abstract][Full Text] [Related]
20. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Niederle N; Krischke W; Bremer K; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
